P Kern. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AnimalsAntiprotozoal Agents/therapeutic useHumansLeishmaniasis/drug therapyLeishmaniasis/physiopathologyLeishmaniasis/transmissionLeishmaniasis, Mucocutaneous/drug therapyLeishmaniasis, Mucocutaneous/physiopathologyLeishmaniasis, Mucocutaneous/transmissionLeishmaniasis, Visceral/drug therapyLeishmaniasis, Visceral/physiopathologyLeishmaniasis, Visceral/transmission
Substances: See more » Antiprotozoal Agents
Year: 1981 PMID: 7259132 DOI: 10.1159/000398098
Source DB: PubMed Journal: Antibiot Chemother (1971) ISSN: 0066-4758